Completing data — refresh the page later to see the latest
128837-71-8Cl.NCC1CCC(C(=O)N[C@@H](Cc2ccccc2)C(=O)Nc2ccc(CC(=O)O)cc2)CC1NAXNMKUKSBHHMP-QCXPCDNBSA-NSafety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
DescriptionPKSI-527 (128837-71-8) is a selective plasma kallikrein inhibitor (Ki = 0.81 μM)1 that can be used for affinity purification of kallikrein2. Synergizes with NO donors to produce antithrombic effects ex-vivo.3 Suppresses collagen-induced arthritis in mouse models.4
UsesPKSI-527 is a new, highly selective plasma kallikrein inhibitor. PKSI-527 can suppress collagen-induced arthritis (CIA) by modifying the kallikrein-kinin system[1].
128837-71-8DTXSID00926216